Kably AA, Acosta MM, Bustamante QY, Sánchez VGE, Lozano ZH, Pérez MJA

Language: Spanish
References: 10
Page: 72-75
PDF size: 111.61 Kb.

ABSTRACT

Introduction: Placenta accreta (PA) is one of the most serious obstetric condition with a high morbidity. The incidence has been reported in up to 1 in 333 births, increasing notably in recent years. Reports of mortality associated are up to 7% and could be even higher. Objective: To report three cases of patients in whom conservative management of the PA associated to placenta previa was performed, to comment the results and to review the literature. Clinical cases: We present three cases of conservative treatment of PA and review literature of several databases such as PubMed, Science, ACOG, and the journal of Ginecología y Obstetricia México. Discussion and conclusions: Currently it is possible to carry out a conservative management considering several approaches, however, it is important to remember that the management should be individualized, but in general has been recommended the interruption of pregnancy between the week 34 to 35. In addition, conservative management is a good option for women wishing to preserve fertility or in cases where it is attached to adjacent organs such as bladder or bowel, increasing the risk of injury.

REFERENCES

1. Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015; 212 (5): 561-568.

2. Eshkoli T, Weintraub AY, Sergienko R, Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol. 2013; 208 (3): 219.e1-7.

3. Bailit JL, Grobman WA, Rice MM, Reddy UM, Wapner RJ, Varner MW et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol. 2015; 125 (3): 683-689.

4. Noguera–Sánchez MF, Karchmer–Krivitzky S, Rabadán–Martínez CE, Antonio–Sánchez P. Acretismo placentario, un problema en aumento. El diagnóstico oportuno como éxito del tratamiento. Ginecol Obstet Mex. 2013; 81 (02): 99-104.

5. Fox KA, Shamshirsaz AA, Carusi D, Secord AA, Lee P, Turan OM et al. Conservative management of morbidly adherent placenta: expert review. Am J Obstet Gynecol. 2015; 213 (6): 755-760.

6. Pacheco LD, Gei AF. Controversies in the management of placenta accreta. Obstet Gynecol Clin North Am. 2011; 38 (2): 313-322, xi.

7. Committee on Obstetric Practice. Committee opinion no. 529: placenta accreta. Obstet Gynecol. 2012; 120 (1): 207-211.

8. Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010; 115 (3): 526-534.

9. Meyer NP, Ward GH, Chandraharan E. Conservative approach to the management of morbidly adherent placentae. Ceylon Med J. 2012; 57 (1): 36-39.

10. Lin K, Qin J, Xu K, Hu W, Lin J. Methotrexate management for placenta accreta: a prospective study. Arch Gynecol Obstet. 2015; 291 (6): 1259-1264.